Proposed PC-CARE Act will coordinate and support Federal prostate cancer research programs
Washington, D.C. May 20, 2022 – ZERO – The End of Prostate Cancer is proud to support yet another lifesaving legislative effort that intends to ensure that various federal programs are coordinated to best fill research gaps, delineate research priorities, and prioritize the most critical work. The Prostate Cancer Community Assistance, Research and Education Act of 2022 (PC-CARE Act – HR 7750), led by Representatives Greg Murphy, MD (NC-03) and Bobby Rush (IL-01), would establish a Prostate Cancer Coordinating Committee to monitor, coordinate, and evaluate the activities of Federal prostate cancer research programs.
The PC-CARE Act, was introduced in May as a part of Cancer Research Month. This proposed legislation will require Federal agencies participating in prostate cancer research to meet regularly together, with patient advocates, caregivers, health care providers, and the largest private funders of prostate cancer research, to chart a path to fight against prostate cancer by identifying the highest priority research areas, gaps in the current research, and disparities in prostate cancer care and outcomes.
”Federal investments in prostate cancer research have yielded tremendous gains in both years and quality of life for prostate cancer patients,” said Jamie Bearse, ZERO’s CEO and President. “By coordinating those efforts across agencies and with the private sector, we can move even faster towards the end of prostate cancer for the sake of millions of men and their loved ones. We’re grateful to Representative Murphy and Representative Dunn for their leadership on behalf of the prostate cancer community.”
The bill proposed a maximum of 24 members on the committee, consisting of representatives from the Centers for Disease Control, Food and Drug Administration, Department of Defense, Department of Veterans Affairs, Centers for Medicare & Medicaid Services, and Health Resources & Services Administration, as well as cancer researchers, clinicians, patients, caregivers, patient groups, and professional medical societies. The Committee will produce a report to Congress every three years.
“The PC-CARE Act is a commonsense approach to good government that will have tremendous benefits for patients and their families,” said Ali Manson, ZERO’s VP of Government Relations and Advocacy. “The more efficiently we can use every research dollar, the sooner we find the next treatment, the next diagnostic tool, and, one day, a cure. Dr. Murphy and Rep. Rush are helping to ensure the future of prostate cancer research and to guarantee that the progress we make benefits all those with the disease.”
Prostate cancer is the second leading cause of cancer death among American men and is the most commonly diagnosed; 1 in 8 American men will be diagnosed with prostate cancer in their lifetime. The American Cancer Society estimates that 268,490 men will be diagnosed with prostate cancer in 2022. Currently, over 3.1 million American men are living with the disease, more than the population of Chicago, America’s third-largest city.
For more information on advocacy efforts regarding prostate cancer across the nation, visit zerocancer.org/advocacy.
About ZERO — The End of Prostate Cancer
ZERO — The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community. From early detection to survivorship, ZERO is the premier resource for prostate cancer patients and their families to access comprehensive support, make meaningful connections, and take action to save lives. Our dedicated national and chapter staff is joined with a growing team of passionate volunteer champions to increase advocacy, awareness, and community engagement to ZERO out prostate cancer. ZERO is recognized with four out of four stars by Charity Navigator and accredited by the Better Business Bureau. ZERO spends more on programs than any other prostate cancer charity, dedicating 85 cents of every dollar to support, education, and research.